EZH2 and chronic myelogenous leukemia, BCR-ABL1 positive: Furthermore, in line with our results, it has been recently reported that the oncogene MYCN regulates EZH2 expression in CML cells, which leads to p21 repression, increasing proliferation and blocking differentiation (Liu et al., 2017).